BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 15703070)

  • 1. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
    Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
    BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.
    Fensterle J; Bergmann B; Yone CL; Hotz C; Meyer SR; Spreng S; Goebel W; Rapp UR; Gentschev I
    Cancer Gene Ther; 2008 Feb; 15(2):85-93. PubMed ID: 18084243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
    Negi VD; Singhamahapatra S; Chakravortty D
    Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli.
    Hotz C; Fensterle J; Goebel W; Meyer SR; Kirchgraber G; Heisig M; Fürer A; Dietrich G; Rapp UR; Gentschev I
    Int J Med Microbiol; 2009 Feb; 299(2):109-19. PubMed ID: 18706861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.
    McKelvie ND; Khan SA; Karavolos MH; Bulmer DM; Lee JJ; DeMarco R; Maskell DJ; Zavala F; Hormaeche CE; Khan CM
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):237-46. PubMed ID: 18177343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria.
    Nagarajan AG; Balasundaram SV; Janice J; Karnam G; Eswarappa SM; Chakravortty D
    Vaccine; 2009 May; 27(21):2804-11. PubMed ID: 19428891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Escherichia coli hemolysin secretion apparatus--a versatile antigen delivery system in attenuated Salmonella.
    Gentschev I; Dietrich G; Mollenkopf HJ; Sokolovic Z; Hess J; Kaufmann SH; Goebel W
    Behring Inst Mitt; 1997 Feb; (98):103-13. PubMed ID: 9382730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of hpaA gene-engineered attenuated Salmonella typhimurium vaccine strain].
    Zhu S; Chen M; Chen J; Hu P; Li G
    Wei Sheng Wu Xue Bao; 2002 Feb; 42(1):27-32. PubMed ID: 12557344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.
    Vendrell A; Gravisaco MJ; Pasetti MF; Croci M; Colombo L; Rodríguez C; Mongini C; Waldner CI
    Vaccine; 2011 Jan; 29(4):728-36. PubMed ID: 21095252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccines.
    Nishikawa H; Sato E; Briones G; Chen LM; Matsuo M; Nagata Y; Ritter G; Jäger E; Nomura H; Kondo S; Tawara I; Kato T; Shiku H; Old LJ; Galán JE; Gnjatic S
    J Clin Invest; 2006 Jul; 116(7):1946-54. PubMed ID: 16794737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
    Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
    Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar Typhimurium in murine tumor models.
    Fu W; Chu L; Han X; Liu X; Ren D
    J Gene Med; 2008 Jun; 10(6):690-701. PubMed ID: 18338832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
    Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of host immune responses stimulated by Salmonella vaccine carrier strains by using different promoters to drive the expression of the recombinant antigen.
    Medina E; Paglia P; Rohde M; Colombo MP; Guzmán CA
    Eur J Immunol; 2000 Mar; 30(3):768-77. PubMed ID: 10741391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAG-1 haplo-insufficiency impairs lung tumorigenesis.
    Götz R; Kramer BW; Camarero G; Rapp UR
    BMC Cancer; 2004 Nov; 4():85. PubMed ID: 15560850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses.
    Bumann D
    Infect Immun; 2001 Dec; 69(12):7493-500. PubMed ID: 11705925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung-targeted expression of the c-Raf-1 kinase in transgenic mice exposes a novel oncogenic character of the wild-type protein.
    Kerkhoff E; Fedorov LM; Siefken R; Walter AO; Papadopoulos T; Rapp UR
    Cell Growth Differ; 2000 Apr; 11(4):185-90. PubMed ID: 10775035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.